Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. type 2 diabetes
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Videos

Refine by
Date

  • Older

Type 2 Diabetes Articles & Analysis: Older

50 articles found

Understanding Skeletal Muscle Microvascular Endothelial Cells: A Crucial Component of Muscle Health

Understanding Skeletal Muscle Microvascular Endothelial Cells: A Crucial Component of Muscle Health

This function is particularly important in the context of metabolic disorders such as obesity and type 2 diabetes. Impaired endothelial function in muscle microvasculature can lead to reduced insulin sensitivity and glucose uptake, further exacerbating metabolic dysregulation. ...

ByCreative Bioarray


Matrix Metalloproteinases (MMPs) - Structure, Sources and Functions

Matrix Metalloproteinases (MMPs) - Structure, Sources and Functions

Dermal fibroblasts and leukocytes are the main sources of MMP, especially MMP-2. Platelets are an important source of MMP-1, MMP-2, MMP-3 and MMP-14. They are present in most connective tissues. MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-12, MMP-13, and MT1-MMP and MT3-MMP are expressed in various vascular tissues and cells. ...

ByCreative Proteomics


Hypoglycemic Functional Factors in Natural Products and Their Mechanisms of Action

Hypoglycemic Functional Factors in Natural Products and Their Mechanisms of Action

Diabetes is a common clinical disease, and with the improvement of living standards, an increase in the number of obese people, and the intensification of aging populations, the incidence of diabetes is increasing year by year. Diabetes has various types and requires long-term treatment. Antidiabetic drugs are essential for ...

ByBOC Sciences


Salivary Protein Glycosylation as a Noninvasive Biomarker for Assessment of Glycemia

Salivary Protein Glycosylation as a Noninvasive Biomarker for Assessment of Glycemia

Abstract Background: Assessment of short-term glycemic control can facilitate monitoring of diabetes development in at-risk individuals and monitoring response to lifestyle modification or medication. We evaluated salivary protein glycosylation levels as a novel, noninvasive, short-term glycemic index in comparison to hemoglobin A1c (HbA1c), fructosamine, 1,5-anhydroglucitol ...

ByDiabetomics, Inc.


Rapid Point-of-Care Test for Determination of C-Peptide Levels

Rapid Point-of-Care Test for Determination of C-Peptide Levels

Assessment of C-peptide levels can identify individuals at risk for or with type 1 diabetes with residual β-cell function in whom β cell-sparing interventions can be evaluated, and can aid in distinguishing type 2 diabetes from Latent Autoimmune Diabetes in Adults and late-onset ...

ByDiabetomics, Inc.


Exploring the Intricate Link Between Bile Acids and Disease

Exploring the Intricate Link Between Bile Acids and Disease

Dysbiosis, an imbalance in gut microbial communities, has been linked to altered bile acid metabolism and, consequently, to diseases like non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes. A landmark study conducted in collaboration with Creative Proteomics investigated the bidirectional relationship between bile acids and the gut ...

ByCreative Proteomics


A Closer Look at Metabolic Disease Models and Diabetes Models

A Closer Look at Metabolic Disease Models and Diabetes Models

Diabetes, specifically Type 1 and Type 2 Diabetes Mellitus, remains one of the most commonly encountered metabolic diseases worldwide. The complexity and diversity of these conditions necessitate the development of detailed medical models for a comprehensive understanding of the diseases. Over time, ...

ByCreative Bioarray


Overview of Diabetes: Prevalence Assessment, Treatment And Prevention

Overview of Diabetes: Prevalence Assessment, Treatment And Prevention

From the perspective of disease type, in all 204 countries and regions, type 2 diabetes cases accounted for more than 80% of all diabetes cases, and in 183 countries and regions with more than 89.7%, the prevalence of type 2 diabetes accounted for 96%. ...

ByHunan Huateng Pharmaceutical Co. Ltd.


What is FGL2?

What is FGL2?

FGL2 and disease Studies have found that FGL2 is highly expressed in microvascular endothelial cells, causing microcirculatory disturbance, promoting myocardial and liver ischemia-reperfusion injury, arthritis, type 2 diabetic heart failure, and type 2 diabetic nephropathy; FGL2 is highly ...

ByCreative Diagnostics


Will Metformin Be Replaced By SGLT-2 Inhibitors

Will Metformin Be Replaced By SGLT-2 Inhibitors

Metformin is a classic first-line hypoglycemic agent for patients with type 2 diabetes, and is an essential drug in combination regimenes. However, as the evidence is updated, the idea of drug selection for first-line treatment is changing. ...

ByHunan Huateng Pharmaceutical Co. Ltd.


Research Progress of Tetrahydrocurcumin

Research Progress of Tetrahydrocurcumin

In addition, our previous study also found that tetrahydrocurcumin has a good therapeutic effect on metabolic syndrome, obesity type 2 diabetes, hypertension, insulin resistance syndrome and other related diseases, and has a wide range of application prospects. 1.Hypoglycemic Effect Murugan P et al. induced type ...

ByHunan Huateng Pharmaceutical Co. Ltd.


Project - Sublingual Dual Incretin Inhibitor (GLP-1/GIP)

Project - Sublingual Dual Incretin Inhibitor (GLP-1/GIP)

BioLingus will position these products in the “epidemic” markets of obesity and type II diabetes : More than 400 MM people suffer from diabetes today. The global type 2 diabetes market is expected to grow to $58.7 billion by 2025, with an annual growth rate of 6.5%, according to ...

ByBioLingus AG


Project - Sublingual insulin+ (fixed dose combination product of insulin and exenatide/liraglutide)

Project - Sublingual insulin+ (fixed dose combination product of insulin and exenatide/liraglutide)

The global human insulin market is projected to surpass USD 40 Billion USD. Our sublingual “insulin+” product will be positioned in a particular segment of this market : it will be prescribed for type II diabetes patients, who do not respond sufficiently to GLP-1 analogues alone. Such a fixed dose combination is already on the market under the brand name Xultophy, which is a ...

ByBioLingus AG


Project - Sublingual IL2 (BL SLIT I)

Project - Sublingual IL2 (BL SLIT I)

The aim of this project is to develop low dose IL-2 for treatment of early onset juvenile Type I diabetes. Low dose injectable IL-2 in animal models has been shown to restore the balance between regulatory and effector T cells and, in this way, can help to reverse autoimmunity and the development of type I ...

ByBioLingus AG


Project - Sublingual Exenatide

Project - Sublingual Exenatide

Liraglutide and exenatide are both belonging to the class of diabetes products called GLP-1 analogues. The GLP-1 analogues have established themselves in the past years as one of the superior drug classes for treatment of diabetes type II in terms of blood glucose lowering and weight loss. Because of the latter, they are being used more and more also in the treatment of obesity. Until now, both ...

ByBioLingus AG


Emerging therapy for HFpEF: SGLT2 inhibitors

Emerging therapy for HFpEF: SGLT2 inhibitors

HFpEF is a complex disease which accounts for more than half of all heart failure (HF) hospital admissions and is an increasing disease burden. [1] The prevalence of HFpEF is climbing, reflecting an increasingly elderly and comorbid population, as well as reinforcing the need for more effective therapies.[2] SGLT2is are a class of anti-diabetic drugs that have ...

ByUltromics Limited


Research Highlight: Stanford University - Case Study

Research Highlight: Stanford University - Case Study

AdvaitaBio’s IPathwayGuide plays significant role in the research of a Stanford investigator. Stanford University is one of the world’s leading research and teaching institutions. With a 1.69 billion dollar annual sponsored research budget, Stanford has been delivering breakthrough discoveries in numerous domains. For over 6 years, Dr. Linda Yip has been conducting research at ...

ByAdvaita Bioinformatics


Is deodorant causing this man’s underarm rash? Let’s diagnose

Is deodorant causing this man’s underarm rash? Let’s diagnose

He initially thought it was an allergic reaction to a new deodorant, but it wasn’t itchy, and it persisted after stopping the deodorant. The patient had a history of type 2 diabetes. On examination, a broad, well-demarcated, thin, scaly plaque was seen extending from the lateral chest over the axilla to the upper arm. ...

ByVisualDx


A new article in JAMA reports self-blood glucose monitoring for type 2 diabetes is not necessary

A new article in JAMA reports self-blood glucose monitoring for type 2 diabetes is not necessary

Med., 2018, one may not need to test themselves several times a day if it is stable type 2 diabetes and on agents (drugs) that do not cause hypoglycemia. ...

ByEpinex Diagnostics Inc


Diabetic Foot Ulcer - Case study

Diabetic Foot Ulcer - Case study

Patient History Patient is a 40-year-old female with a history of type 2 diabetes. Patient presented to the Emergency Room with a diabetic foot ulcer and infection. ...

ByAcera Surgical Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT